Predict your next investment

Private Equity
dnacapital.com.br

See what CB Insights has to offer

Investments

11

About DNA Capital

DNA Capital is a Brazilian private equity firm focused on the healthcare sector.

DNA Capital Headquarter Location

R. Joaquim Floriano, 413 11º and, cjto 112

Sao Paulo, 04534-011,

Brazil

+ 55 (11) 5682-3230

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest DNA Capital News

High Alpha Invests in Cured’s $10M Series A

Sep 15, 2021

by High Alpha September 15, 2021 – BOULDER, CO. – Cured , a healthcare digital marketing and customer relationship management (CRM) platform, today announced it has closed an oversubscribed $10 million Series A funding round. The round was led by DNA Capital and included participation from new investors CU Healthcare Innovation Fund and UCHealth . Existing investors High Alpha , Waterline Ventures , Matchstick Ventures , and Headwater Ventures also participated. As a part of the round, Partha Mishra , Partner at DNA Capital and experienced healthcare executive, will join Cured’s Board of Directors. “Today’s healthcare organizations have substantial opportunity to differentiate themselves from their competitors by providing their consumers with the digital experiences individuals and their families have become accustomed to in their interactions with their favorite retail, consumer goods, or even financial services brands,” said Andrew Sawyer , co-founder and Chief Executive Officer of Cured. “The reality is that the existing digital marketing & CRM platforms that enable these experiences outside of healthcare are not well suited to meet the unique needs of healthcare. The industry has particular security, compliance, and data needs. Moreover, patient and member experiences in healthcare are highly contextual. The ability to educate and provide digital interactions specific to an individual’s healthcare needs throughout the patient or member journey can markedly improve engagement and loyalty.” Since launching in May 2018, Cured has partnered with leading health systems, healthcare services, and digital health organizations to transform their growth and experience strategies through technology. To date, Cured’s clients have sent over 35 million interactions through the company’s solutions. Such interactions focus on driving consumers to preventative services, making individuals aware of convenient healthcare options applicable to their needs, and providing guidance along specific care journeys to improve adherence and engagement. “Healthcare organizations have access to more data about their customers than arguably any other industry. However, their ability to mobilize and use this data to create meaningful experiences for their customers lags behind most of their industry peers,” stated Ashmer Aslam , co-founder and Chief Technology Officer of Cured. “Our platform hopes to solve that problem by taking first party-data and making it actionable. We achieve this by applying analytics and machine learning that is contextually aware of the target audience; and, in turn, we can apply predictions to create meaningful audience segmentation to maximize personalization, precision, and action.” In conjunction with the funding, the company launched Curations, a catalog of over 70+ prebuilt patient and customer journey campaigns to aid healthcare organizations in attracting, engaging, and retaining healthcare consumers. Curations include audience and segmentation configuration, content and creative templates, and automation available out of the box to support the strategies that matter most to leading healthcare organizations. “We, at DNA Capital, are delighted to partner with Cured as they are poised to scale their healthcare native, enterprise-grade digital marketing and CRM solutions to transform how healthcare organizations build lasting relationships with their customers,” said Mishra. “We are equally excited to back the top notch founding team – a rare blend of talent with deep understanding of health systems strategy, experience in architecting scalable SaaS solutions, and proven ability to cultivate trusted relationships with enterprise customers.” Cured will use the funding to accelerate the advancement of its Digital Marketing and Insights platform. Further, the funding will support the continued growth of its team of healthcare and customer experience experts across its locations in Boulder, Chicago, and Indianapolis. The team is actively hiring talent in software engineering, business development, and customer delivery. For more information on hiring and openings, visit: cured.health/about#join-us Sign up for our Newsletter Stay up to date on the latest with High Alpha, our portfolio companies, and the future of enterprise cloud. Jet Stream Subscription

DNA Capital Investments

11 Investments

DNA Capital has made 11 investments. Their latest investment was in Cured as part of their Series A on September 9, 2021.

CBI Logo

DNA Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/15/2021

Series A

Cured

$10M

Yes

1

9/3/2021

Series B

The Carevoice

No

1

4/14/2021

Series B

Beep Saude

$19.4M

No

1

4/15/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

2/26/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/15/2021

9/3/2021

4/14/2021

4/15/2020

2/26/2020

Round

Series A

Series B

Series B

Series B

Series A

Company

Cured

The Carevoice

Beep Saude

Subscribe to see more

Subscribe to see more

Amount

$10M

$19.4M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

DNA Capital Acquisitions

2 Acquisitions

DNA Capital acquired 2 companies. Their latest acquisition was Memed on April 29, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/29/2021

Series B

$4.6M

Acq - Fin

3

10/25/2018

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/29/2021

10/25/2018

Investment Stage

Series B

Companies

Subscribe to see more

Valuation

Total Funding

$4.6M

$99M

Note

Acq - Fin

Subscribe to see more

Sources

3

10

DNA Capital Team

3 Team Members

DNA Capital has 3 team members, including current Chief Financial Officer, Ricardo Rezende.

Name

Work History

Title

Status

Alexis Labrecque

Founder

Current

Ricardo Rezende

Chief Financial Officer

Current

Mario Sergio Ribeiro

Managing Director

Current

Name

Alexis Labrecque

Ricardo Rezende

Mario Sergio Ribeiro

Work History

Title

Founder

Chief Financial Officer

Managing Director

Status

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.